National Pancreatic Cancer Clinical Trials Awareness Month Campaign Sheds Light On Myths And Enrollment Barriers Surrounding Clinical Trials

This January, in recognition of National Pancreatic Cancer Clinical Trials Awareness Month, the Pancreatic Cancer Action Network (PanCAN) strongly encourages all pancreatic cancer patients to consider clinical trials at diagnosis and during every treatment decision. Clinical trials often provide the best treatment options for pancreatic cancer patients, but myths and misconceptions about trials remain prevalent. Pancreatic cancer is the third leading cause of cancer-related death in the United States, and according to the most recent American Cancer Society’s Facts and Figures report from 2018, only 9 percent of patients diagnosed with pancreatic…

Read More